Fig. 1From: Predicting pathological complete response (pCR) after stereotactic ablative radiation therapy (SABR) of lung cancer using quantitative dynamic [18F]FDG PET and CT perfusion: a prospective exploratory clinical studySummary of patient enrollment. SABR stereotactic ablative radiation therapy, FDG fluorodeoxyglucose, PET positron emission tomography, CTP computed tomography perfusionBack to article page